Susquehanna Fundamental Investments’s Vir Biotechnology VIR Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,159	Closed	-$91.4K	–	691
2025 Q4	$91.4K	Sell	15,159 -248,738	-94%	-$1.48M	﹤0.01%	537
2025 Q3	$1.51M	Sell	263,897 -36,460	-12%	-$186K	0.06%	274
2025 Q2	$1.51M	Sell	300,357 -31,444	-9%	-$169K	0.04%	386
2025 Q1	$2.15M	Buy	331,801 +130,616	+65%	+$1.16M	0.04%	512
2024 Q4	$1.48M	Buy	+201,185	New	+$1.59M	0.02%	608
2024 Q2	$135K	Buy	+15,200	New	+$146K	﹤0.01%	881
2021 Q1	–	Sell	-14,211	Closed	-$381K	–	1618
2020 Q4	$381K	Buy	+14,211	New	+$462K	0.01%	1192

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return